Conditions: Traveler's Diarrhea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 835
Healthy volunteers: no

Brief summary:
The purpose of this study is to prove the non-inferiority of Rifamycin SV-MMX® versus Ciprofloxacin for the treatment of adults with traveller's diarrhoea.

Detailed description:

Arms:
arm 1: Rifamycin SV-MMX® 200 mg tablets arm 2: Ciprofloxacin 500 mg capsules

Interventions: intervention 1: Rifamycin SV-MMX® intervention 2: Ciprofloxacin
Intervention descriptions: intervention 1: 2 Rifamycin SV-MMX® 200 mg tablets and 1 placebo to ciprofloxacin capsule, b.i.d. intervention 2: 1 ciprofloxacin 500 mg capsule and 2 placebos to Rifamycin SV-MMX® 200 mg tablets, b.i.d.

Protocol document: